Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Vaccine for Malignant Catarrhal Fever?
The annual wildebeest migration - one of the world's greatest spectacles but also a real threat to the livelihood of local farms.
The annual migration of over a million wildebeest across the Serengeti and Maasai Mara is often described as one of the greatest spectacles on earth. However, this natural wonder poses a real threat to the livelihood of local farmers whose cattle are essential to their economic and social welfare.

RESEARCHERS led by David Haig, Professor of Animal Infection and Immunity at The University of Nottingham have already developed a candidate MCF vaccine for use in cattle. The next step is to test it in field conditions. Over the next three years his research team will test the vaccine in Tanzania, develop it further as required and then look to make a new vaccine for a sheep virus which is very similar to the wildebeest virus and causes MCF in livestock in other parts of the world, including Europe, Indonesia, Australasia and the Americas.

Professor Haig, from the School of Veterinary Medicine and Science, said: “The quest for a vaccine for Malignant Catarrhal Fever goes back to the middle of the last century. We have the first successful vaccine candidate and this is eagerly sought by the pastoralists and farmers in Eastern and Southern Africa, who have been lobbying for this for many years. We also have a strategy to develop a vaccine for a related virus causing MCF elsewhere in the world and are delighted that BBSRC/DFID have given us the opportunity to develop this.”

The research project is part of a £13m initiative... to support farmers and families in the developing world.
The research project is part of a £13m initiative funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Department for International Development (DFID) to support farmers and families in the developing world.

Professor Haig will be working with experts from Glasgow University, the Moredun Research Institute, in Scotland, and Sokoine University of Agriculture in Tanzania, the Tanzania Wildlife Research Institute (TAWIRI), Tanzania National Parks (TANAPA), Central Veterinary Laboratory, and VETAID, Tanzania.

Agriculture is vital for the livelihoods of 75 per cent of the world's poor. Food demand is predicted to increase by 50 per cent by 2030. The BBSRC and DFID have joined forces to harness the UK's world-class bioscience base to address the challenges posed by livestock diseases and work with developing countries to provide practical and sustainable solutions.

‘Combating Infectious Diseases of Livestock for International Development’ is an initiative made up of 16 projects, involving 16 UK institutions and eight other countries, which over the next four years will look at some of the most prevalent, damaging and costly diseases of livestock in developing countries and work with more than 20 overseas institutes to not only control or prevent these diseases but also to build scientific capacity at a local and national level within these countries to enable them to manage these diseases and apply new findings and technologies to other disease areas, in both livestock and humans.

‘Combating Infectious Diseases of Livestock for International Development’ is an initiative made up of 16 projects, involving 16 UK institutions and eight other countries, which will look at some of the most prevalent, damaging and costly diseases of livestock in developing countries.
The projects will also offer significant benefits to farmers and consumers in the UK — animal diseases do not respect national boundaries and are estimated to have cost the UK economy over £15 billion over the past 15 years. Several of the diseases being tackled by the initiative are spreading across countries and continents and some are already a direct threat to UK livestock such as Foot and Mouth disease and Bluetongue virus. New technologies developed as part of this research could also be transferable for use to combat other animal diseases and possibly human ones too.

Science and Innovation Minister Lord Drayson said: “This collaboration demonstrates the UK's determination to share our world-leading science in the search for improved treatments and diagnostic tools in animal health. Animal disease is a deadly threat that leaves no corner of the Earth untouched. This research will allow communities to protect food chains and economies at home and in developing countries.”

By bringing together the best science and the brightest minds from around the globe, the initiative aims to generate workable solutions on the ground to improve animal welfare, productivity and ultimately enhance the lives of millions of people.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.